Jerry Cronin
Ask VT AI
View News Summary
- Democratic Rep. Jasmine Crockett faces allegations of staff abuse and a focus on building an online influencer persona rather than legislative duties.
- Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
- Wendy's lowers guidance amid revenue decline, but focuses on global expansion and shareholder returns.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Democratic Rep. Jasmine Crockett faces allegations of staff abuse and a focus on building an online influencer persona rather than legislative duties.
- Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
- Wendy's lowers guidance amid revenue decline, but focuses on global expansion and shareholder returns.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Jerry Cronin
News from Jerry Cronin